Phreesia (NYSE:PHR) Trading Down 2.4% – What’s Next?

Phreesia, Inc. (NYSE:PHR)’s stock price fell 2.4% during trading on Friday . The company traded as low as $24.62 and last traded at $24.84. 107,533 shares changed hands during trading, a decline of 74% from the average session volume of 418,204 shares. The stock had previously closed at $25.45.

Wall Street Analyst Weigh In

A number of research firms recently commented on PHR. Citigroup upped their price target on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Robert W. Baird reduced their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Finally, Truist Financial boosted their price objective on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia currently has an average rating of “Buy” and a consensus price target of $31.33.

Phreesia Stock Down 0.3 %

The stock’s 50-day moving average price is $27.31 and its two-hundred day moving average price is $23.98. The stock has a market capitalization of $1.47 billion, a PE ratio of -17.26 and a beta of 1.03. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Insider Buying and Selling

In related news, COO Evan Roberts sold 3,519 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $30.06, for a total value of $105,781.14. Following the transaction, the chief operating officer now owns 741,197 shares in the company, valued at $22,280,381.82. The trade was a 0.47 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel Allison C. Hoffman sold 3,495 shares of the company’s stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $24.88, for a total transaction of $86,955.60. Following the completion of the transaction, the general counsel now owns 116,296 shares in the company, valued at approximately $2,893,444.48. The trade was a 2.92 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 163,322 shares of company stock worth $4,631,915 in the last quarter. Corporate insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On Phreesia

A number of hedge funds have recently bought and sold shares of PHR. Quest Partners LLC boosted its stake in Phreesia by 5,361.8% in the 3rd quarter. Quest Partners LLC now owns 31,296 shares of the company’s stock worth $713,000 after purchasing an additional 30,723 shares in the last quarter. Intech Investment Management LLC bought a new position in Phreesia during the 3rd quarter valued at about $316,000. Charles Schwab Investment Management Inc. lifted its stake in Phreesia by 3.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 447,239 shares of the company’s stock valued at $10,193,000 after acquiring an additional 16,112 shares during the period. Champlain Investment Partners LLC lifted its stake in Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after acquiring an additional 97,847 shares during the period. Finally, Dynamic Technology Lab Private Ltd bought a new position in Phreesia during the 3rd quarter valued at about $549,000. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.